Replies to post #250 on Ocular Therapeutix Inc (OCUL)

[Number sleven]

Kiwi, I agree. I also don't want to spend time in another biotech while it launches a drug. If the eypt p2 trial is successful, (it should be) I intend switching to ocular. They should get a nice bump on p3 outcome. I Will leave and go back for the eypt p3.
What are your thoughts?
Sleven,

[Number sleven]

Kiwi, Take a look at the share count for both companies.
Sleven,